CD36 and metabolic dysfunction-associated steatotic liver disease: Zeng et al., found that fatty acid translocase (FAT/CD36) on the mitochondrial membrane was heavily palmitoylated in NAFLD, which reduced its ability to transfer long-chain fatty acids into mitochondria and inhibited fatty acid oxidation [33].